NCT06732388 2026-04-13
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
Clinical Trials
35 trialsNCT03753659 2026-03-23
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
NCT02437071 2025-12-05
Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00712712 2025-08-29
MEDOR
Institut Bergonié
Phase 2 Completed
NCT07095803 2025-07-31
Ivonescimab (PD-1/VEGF Bispecific Antibody) Plus Radiofrequency Ablation for Multiple Advanced Tumors After PD-1 Therapy Failure
Fudan University
Phase 2 Not yet recruiting
NCT00813293 2023-06-13
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
Beth Israel Deaconess Medical Center
Phase 2 Completed
NCT02821754 2023-03-28
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT04698252 2022-08-08
LARA
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT05485909 2022-08-03
Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM
Sun Yat-sen University
Phase 2 Unknown
NCT03101475 2022-05-31
ILOC
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00029029 2020-08-12
Radiofrequency Ablation in Relieving Pain in Patients With Bones Metastases
Mayo Clinic
Phase 2 Completed
NCT00024076 2020-08-03
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Completed
NCT04150744 2020-07-08
RFA Plus Carrizumab vs Carrizumab Alone for HCC
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT03750396 2019-02-15
CLEAR
Gangnam Severance Hospital
Phase 2 Unknown
NCT00004136 2018-11-06
Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00004142 2018-10-26
Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01986829 2018-09-19
Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy
Washington University School of Medicine
Phase 2 Terminated
NCT00373152 2017-12-05
MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer
Masonic Cancer Center, University of Minnesota
Phase 2 Withdrawn
NCT00408772 2017-06-09
Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer
University of California, Davis
Phase 2 Withdrawn
NCT00030563 2017-04-17
Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver
University of Washington
Phase 2 Completed
NCT00019604 2017-02-03
Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT00922948 2016-07-27
Cryoablation Versus Radiofrequency Ablation for Small Renal Masses
St. Joseph's Healthcare Hamilton
Phase 2 Withdrawn
NCT02468076 2016-05-11
IGNITE-1
Universitaire Ziekenhuizen KU Leuven
Phase 2 Completed
NCT02487693 2016-02-23
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma
The First People's Hospital of Changzhou
Phase 2 Active not recruiting
NCT02490748 2016-02-23
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer
The First People's Hospital of Changzhou
Phase 2 Active not recruiting
NCT02634502 2015-12-18
Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis
Fudan University
Phase 2 Unknown
NCT00019955 2015-04-29
Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)
National Cancer Institute (NCI)
Phase 2 Completed
NCT01628458 2015-02-02
RFA of LAPC
UMC Utrecht
Phase 2 Completed
NCT01669668 2014-07-16
Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma)
Washington University School of Medicine
Phase 2 Withdrawn
NCT01858207 2013-05-23
Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient
Chang Gung Memorial Hospital
Phase 2 Unknown
NCT00043004 2012-09-24
Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT00006255 2010-06-11
Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00039507 2010-02-12
Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer
Fox Chase Cancer Center
Phase 2 Completed
NCT00868647 2009-09-01
Radiofrequency Ablation (RFA) Of Tumors Acquired In Childhood
Seattle Children's Hospital
Phase 2 Suspended
NCT00180856 2005-09-16
Radiofrequency Ablation of Lung Tumors
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Completed